Table I Index
Table of Contents
|
Table I - 89 Wayne Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 379 | 389.6 | 186 | 448.6 | 193 | 348.3 |
| Oral cavity and pharynx | 9 | 9.0** | * | # | 5 | 7.9** |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 66 | 68.2 | 39 | 95.6 | 27 | 47.5 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | 5 | 4.4** | * | # | * | # |
| Colon excluding rectum | 29 | 27.3 | 15 | 34.7** | 14 | 22.8** |
| Rectum and rectosigmoid | 16 | 18.8** | 11 | 29.2** | 5 | 10.5** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 5 | 5.7** | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 75 | 76.2 | 44 | 104.5 | 31 | 56.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 5 | 5.6** | 5 | 13.1** | * | # |
| Lung and bronchus | 70 | 70.6 | 39 | 91.4 | 31 | 56.4 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 7 | 7.3** | * | # | 5 | 9.4** |
| Melanoma of the skin | 5 | 5.0** | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 55 | 57.1 | * | # | 55 | 102.8 |
| Female genital system | 28 | 30.4 | -- | -- | 28 | 55.9 |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 12 | 13.0** | -- | -- | 12 | 23.8** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 12 | 13.3** | -- | -- | 12 | 24.6** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 58 | 59.4 | 58 | 137.0 | -- | -- |
| Prostate gland | 57 | 58.3 | 57 | 134.6 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 32 | 29.4 | 20 | 46.0 | 12 | 16.0** |
| Urinary bladder | 20 | 17.8 | 13 | 29.8** | 7 | 8.7** |
| Kidney and renal pelvis | 10 | 10.0** | 6 | 13.8** | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 6 | 5.6** | * | # | * | # |
| Brain | 6 | 5.6** | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 5 | 4.5** | * | # | 5 | 8.0** |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 18 | 19.4** | 5 | 13.5** | 13 | 24.2** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 16 | 16.5** | 5 | 13.5** | 11 | 18.7** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 13 | 15.8** | 8 | 23.2** | 5 | 9.5** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | * | # | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||